We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
-8.73%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$308M
AUM Growth
-$44.2M
Cap. Flow
-$4.71M
Cap. Flow %
-1.53%
Top 10 Hldgs %
25.53%
Holding
393
New
63
Increased
64
Reduced
89
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.58M
2
CAG icon
Conagra Brands
CAG
+$6.41M
3
GIS icon
General Mills
GIS
+$6.28M
4
BDX icon
Becton Dickinson
BDX
+$6.25M
5
PG icon
Procter & Gamble
PG
+$6.16M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$8.69M
2
ZBRA icon
Zebra Technologies
ZBRA
+$8.06M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$7.68M
4
MCO icon
Moody's
MCO
+$7.1M
5
ZTS icon
Zoetis
ZTS
+$6.57M

Sector Composition

Rank Sector Weight
1 Healthcare 18.62%
2 Financials 14.7%
3 Energy 12.88%
4 Consumer Staples 11.59%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRVL icon
276
CorVel
CRVL
$3.16B
$5K ﹤0.01%
96
– –
DY icon
277
Dycom Industries
DY
$12.2B
$5K ﹤0.01%
52
– –
FBP icon
278
First Bancorp
FBP
$4.42B
$5K ﹤0.01%
385
– –
FHI icon
279
Federated Hermes
FHI
$4.76B
$5K ﹤0.01%
154
– –
FIX icon
280
Comfort Systems
FIX
$59.7B
$5K ﹤0.01%
55
– –
FWRD icon
281
Forward Air
FWRD
$643M
$5K ﹤0.01%
49
– –
GHC icon
282
Graham Holdings Company
GHC
$4.96B
$5K ﹤0.01%
9
– –
HAE icon
283
Haemonetics
HAE
$3.92B
$5K ﹤0.01%
+81
New +$4.79K
IPAR icon
284
Interparfums
IPAR
$3.77B
$5K ﹤0.01%
62
– –
MLI icon
285
Mueller Industries
MLI
$15.4B
$5K ﹤0.01%
360
– –
NNI icon
286
Nelnet
NNI
$4.5B
$5K ﹤0.01%
58
– –
NTCT icon
287
NETSCOUT
NTCT
$2.8B
$5K ﹤0.01%
162
– –
PSMT icon
288
Pricesmart
PSMT
$5.3B
$5K ﹤0.01%
65
– –
RUSHA icon
289
Rush Enterprises Class A
RUSHA
$6.24B
$5K ﹤0.01%
141
– –
SANM icon
290
Sanmina
SANM
$10.9B
$5K ﹤0.01%
125
– –
TR icon
291
Tootsie Roll Industries
TR
$2.99B
$5K ﹤0.01%
169
– –
VRRM icon
292
Verra Mobility
VRRM
$729M
$5K ﹤0.01%
308
– –
PDCO
293
DELISTED
Patterson Companies, Inc.
PDCO
$5K ﹤0.01%
161
– –
MANT
294
DELISTED
Mantech International Corp
MANT
$5K ﹤0.01%
57
– –
IBTX
295
DELISTED
Independent Bank Group, Inc.
IBTX
$5K ﹤0.01%
+67
New +$4.68K
AAT
296
American Assets Trust
AAT
$1.39B
$4K ﹤0.01%
137
– –
ABR icon
297
Arbor Realty Trust
ABR
$978M
$4K ﹤0.01%
287
– –
CHRD icon
298
Chord Energy
CHRD
$7.66B
$4K ﹤0.01%
+34
New +$4.98K
CNO icon
299
CNO Financial Group
CNO
$5.14B
$4K ﹤0.01%
211
– –
F icon
300
Ford
F
$55.9B
$4K ﹤0.01%
350
-459,681
-100% -$6.29M
10 11
12
13 14

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Contravisory Investment Management held 393 positions worth $308M, down 13% from $352M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management's Q2 2022 filing shows 63 new, 64 increased, 89 reduced and 70 closed positions. Its largest new stake was Conagra Brands: 188,092 shares worth $6.44M. The largest sale was Accenture, an estimated $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Energy.

  • Contravisory Investment Management's largest Q2 2022 buy was Conagra Brands: 188,092 shares worth $6.44M.
  • Contravisory Investment Management added most to Merck in Q2 2022, an estimated $6.58M increase.
  • Contravisory Investment Management's biggest Q2 2022 reduction was Accenture, cutting an estimated $8.69M.
  • Contravisory Investment Management fully exited Zebra Technologies in Q2 2022, selling an estimated $8.06M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $308M portfolio in Q2 2022.
  • Contravisory Investment Management opened 63 new positions and closed 70 in Q2 2022.
  • Contravisory Investment Management's portfolio value fell 13% quarter-over-quarter to $308M.

Based on Contravisory Investment Management's 13F filing for Q2 2022, filed 13 Jul 2022.